quarterarcade|尖峰集团(600668.SH)：子公司获得他氟前列素滴眼液药品注册证书

Gelonghui May 6 丨 Jianfeng Group (600668quarterarcade.SH) Announcementquarterarcade, recentlyquarterarcadeZhejiang Jianfeng Pharmaceutical Co., Ltd.(hereinafter referred to as "Jianfeng Pharmaceutical"), a wholly-owned subsidiary of the company, received the "Drug Registration Certificate" of tafluprost eye drops approved and issued by the State Food and Drug Administration (Certificate No.: 2024S00682). This product is used to reduce elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension.